Last Week’s Top 3 Most Read Posts on Pulmonary Hypertension

ph top 3

Read the articles here:

1. PAH Drug Associated with Fewer Deaths, Disease Complications in Phase 3 Study

2. New PAH Drug from Actelion Approved by FDA

3. Reata PH Study Expands to Include Patients with Interstitial Lung Disease

 

Average Rating
0 out of 5 stars. 0 votes.
My Rating:

Leave a Comment

Your email address will not be published. Required fields are marked *